INX-189: Phase Ib started

Inhibitex began a 2-part, double-blind, placebo-controlled, U.S. Phase Ib trial of INX-189 in 60-70 patients. In the first part of the trial, cohorts of 10 treatment-naïve patients with HCV genotype 1...